Company Nicodiab Srl with Fiscal Code 14468282
recorded a turnover of 2024 of
295.685,
with a net profit of
90.330
and having an average number of employees of
3.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Nicodiab Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
88.949
102.163
140.558
153.732
179.253
211.263
219.327
136.367
207.559
295.685
Total Income - EUR
90.795
102.669
141.872
155.102
180.590
212.328
219.505
136.373
207.566
295.836
Total Expenses - EUR
77.945
50.092
59.321
62.023
69.837
71.216
123.272
121.288
133.799
196.808
Gross Profit/Loss - EUR
12.850
52.577
82.552
93.079
110.753
141.112
96.233
15.085
73.766
99.028
Net Profit/Loss - EUR
8.284
47.171
80.704
91.531
108.949
139.234
94.132
13.858
71.732
90.330
Employees
3
3
2
3
3
3
3
3
3
3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 43.3%, from 207.559 euro in the year 2023, to 295.685 euro in 2024.
The Net Profit increased by 18.999 euro, from 71.732 euro in 2023, to 90.330 in the last year.
Check the financial reports for the company - Nicodiab Srl
Financial Rating - NICODIAB SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Nicodiab Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Nicodiab Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Nicodiab Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
175.120 euro in 2024 which includes Inventories of
3.956 euro, Receivables of
67.520 euro and cash availability of
103.644 euro.
The company's Equity was valued at
90.379 euro, while total Liabilities amounted to
369.408 euro.
Equity increased by 18.999 euro, from 71.781 euro in 2023, to 90.379 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Nicodiab Srl